Skip to main content

Table 4 Enriched DO terms with p-value <0.01 in all the modules

From: Comparisons of gene coexpression network modules in breast cancer and ovarian cancer

No.

DO ID

Description

p-value

14

DOID:3770

Pulmonary fibrosis

7.40E-04

 

DOID:1602

Lymphadenitis

7.40E-04

 

DOID:9942

Lymph node disease

7.40E-04

 

DOID:1936

Atherosclerosis

7.40E-04

 

DOID:1036

Chronic leukemia

7.40E-04

 

DOID:2348

Arteriosclerotic cardiovascular disease

7.40E-04

 

DOID:2349

Arteriosclerosis

7.79E-04

 

DOID:3459

Breast carcinoma

1.10E-03

 

DOID:3082

Interstitial lung disease

1.94E-03

 

DOID:0070004

Myeloma

3.21E-03

 

DOID:75

Lymphatic system disease

3.21E-03

 

DOID:4960

Bone marrow cancer

3.21E-03

 

DOID:865

Vasculitis

5.68E-03

 

DOID:13378

Kawasaki disease

7.82E-03

 

DOID:9538

Multiple myeloma

9.27E-03

15

DOID:2730

Epidermolysis bullosa

3.27E-04

 

DOID:2731

Vesiculobullous skin disease

3.27E-04

 

DOID:299

Adenocarcinoma

6.72E-03

 

DOID:4766

Embryoma

9.26E-03

 

DOID:688

Embryonal cancer

9.71E-03

17

DOID:700

Mitochondrial metabolism disease

1.77E-03

33

DOID:1882

Atrial heart septal defect

2.16E-03

 

DOID:9477

Pulmonary embolism

2.16E-03

 

DOID:1681

Heart septal defect

8.06E-03

 

DOID:1682

Congenital heart disease

8.06E-03

 

DOID:2214

Inherited blood coagulation disease

8.06E-03

 

DOID:780

Placenta disease

8.13E-03

34

DOID:2893

Cervix carcinoma

1.62E-03

 

DOID:4362

Cervical cancer

1.62E-03

 

DOID:120

Female reproductive organ cancer

4.60E-03

37

DOID:10652

Alzheimer’s disease

8.20E-03

 

DOID:680

Tauopathy

8.20E-03

38

DOID:3113

Papillary carcinoma

3.66E-03

 

DOID:2394

Ovarian cancer

4.14E-02